GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

RAS Full Form: The full form of RAS is Rajasthan Administrative Service. It is a state-level civil services examination conducted by the Rajasthan Public Service Commission (RPSC) to recruit ...

GSK plc announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted indications are for ...

In Japan, the submitted indications are for treatment of severe or refractory bronchial asthma and CRSwNP inadequately controlled with ... Number of subjects included in the Full Analysis of SWIFT-1: ...

SSC Full Form: The full form of SSC is Staff Selection Commission. The SSC is a major body of the Department of Personnel and Training (DoPT) and it includes a Chairman, two members, and a ...

Similarly, the ANCHOR trials showed that depemokimab effectively reduced nasal polyp size and obstruction in CRSwNP patients compared to placebo. Depemokimab, a monoclonal antibody targeting ...

LONDON - GSK plc (LSE/NYSE: LON:GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...

Kaivan Khavandi, SVP at GSK, stated, "Simultaneous regulatory submissions for two indications highlight our confidence in depemokimab to help reduce the burden of both asthma and CRSwNP for ...

Thymic stromal lymphopoietin (TSLP) and interleukin (IL)-4 levels are elevated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and correlated with increased preoperative fractional ...